James “Jamie” Levine has joined Primordial Genetics’ Board of Directors, bringing deep executive experience in industrial biotechnology and finance to the company’s leadership. Mr. Levine is CEO and a member of the Board of Directors of Annai Systems, a private a leading genomic data analysis company, and CEO and a member of the Board of Directors of Sapphire Energy, a private company creating human nutraceutical products from outdoor algae cultivation. Previously Mr. Levine was CEO at Verenium Corporation, a NASDAQ-Listed company that developed enzyme products for diverse end-markets including animal feed. Verenium was acquired by the chemical company BASF in 2013. Prior to joining Verenium, Mr. Levine was a Managing Director in the investment banking department of Goldman Sachs & Co. where he served clients in the Healthcare and Energy industries. Mr. Levine received an MBA degree from the Wharton School of the University of Pennsylvania and a BA from Brandeis University.
James E. Levine joins Primordial Genetics’ Board of Directors
(858) 366-0770 info@primordialgenetics.com
Related Articles
-
Primordial Genetics receives NIH Grant: Synthetic biology E. coli strain development for expression of functional human GPCRs with roles in human disease
Sabrina Baffert, , News, 0
The principal aim of this project is to apply a novel synthetic biology approach to develop protein expression strains...
-
Primordial Genetics and Bayer announce research collaboration to enhance crop performance
Sabrina Baffert, , News, 0
Primordial Genetics and Bayer CropScience LP announced today the establishment of a research collaboration to evaluate Primordial Genetics’ proprietary...
-
Primordial Genetics goes live on Fundable
Sabrina Baffert, , News, 0
Primordial Genetics joins Fundable, a crowd-sourcing platform and investment community that features small companies and allows them to connect...
-
-
-
Egle Thomas PhD, MBA joins Primordial Genetics as business consultant.
Sabrina Baffert, , News, 0
Egle B. Thomas PhD, MBA has joined Primordial Genetics Inc as a strategic business consultant. Egle has over 13...
-
-
Primordial Genetics signs R&D Agreement for pharmaceutical manufacturing.
Sabrina Baffert, , News, 0
Following the launch of an R&D project for improvement of an enzyme used for manufacturing high-value pharmaceuticals in November...
0 Comments